Compound Detail
CHEMBL58653
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL58653 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | YOBXBUIFJQYXKU-UHFFFAOYSA-N |
2
Targets
3
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
479.6
MW (Da)
1.62
ALogP
8
HBA
4
HBD
188.2
PSA (Ų)
0.12
QED
0
Ro5 Violations
16
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 3 meas. best 4.7
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Human immunodeficiency virus type 1 reverse transcriptase CHEMBL247 | EC50 | 4.7 | 4.7 | 20000.0 | 1 |
| ADMET CHEMBL612558 | EC50 | 4.17 | 4.145 | 68000.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Human immunodeficiency virus type 1 reverse transcriptase | EC50 | = | 20000.0 | nM | 4.7 | Effective concentration required to achieve 50% inhibition of HIV-1 LAI replicat... | 10821705 |
| ADMET | EC50 | = | 68000.0 | nM | 4.17 | Effective concentration required to achieve 50% inhibition of HIV-2 D194 multipl... | 10821705 |
| ADMET | EC50 | = | 75000.0 | nM | 4.12 | Effective concentration required to achieve 50% inhibition of HIV-1 IIIB multipl... | 10821705 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 10821705 | 10.1021/jm991125l | ADMET | 3 |
| 10821705 | 10.1021/jm991125l | Human immunodeficiency virus type 1 reverse transcriptase | 2 |
| 10821705 | 10.1021/jm991125l | MT4 | 2 |
Data from ChEMBL 36 via Core Engine